www.dimericon.com

The startup is developing a platform that utilizes computational biology to identify novel druggable targets in challenging oncology pathways. This approach aims to enhance the discovery of effective therapies for cancers that have historically been difficult to treat.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup is developing a platform that utilizes computational biology to identify novel druggable targets in challenging oncology pathways. This approach aims to enhance the discovery of effective therapies for cancers that have historically been difficult to treat.